bearish

Innovent Biologics (信达生物) Placement - Back on the Market but This Time with Secondary Selldown

480 Views22 Jul 2020 19:49
Innovent Biologics Inc (1801 HK) is looking to raise about U$290m to fund expansion and concurrently, shareholders are looking to sell about 33.8m...
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x